Skip to main content

Table 1 Demographic distrubition of the patients

From: The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Sex

n(%)

 Male

6 (%30)

 Female

14 (%70)

Age, year, mean ± SD

55.15 ± 14 (32–87)

Primary cancer diagnosis

 Colorectal cancer

7 (%35)

 Gynecologic cancer

10 (%50)

 Retroperitoneal sarcoma

3 (%15)

Preoperative hydronephrosis

 No

8 (%40)

 Right

4 (%20)

 Left

5 (%25)

 Bilateral

3 (%15)

Visceral organ resection

 Low anterior resection

7 (%35)

 Total proctocolectomy

2 (%10)

 Total colectomy

1 (%5)

 Hemicolectomy

2 (%10)

 A.P.R

2 (%10)

 Pelvic exenteration

3 (%15)

 TAH + BSO

3 (%15)

Types of ureteral reconstructions

 Ureteroureterostomy

2 (%10)

 Trans ureteroureterostomy

6 (%30)

 Ureteroneocystostomy

5 (%25)

 Boari flap

4 (%20)

 Ureterosigmoidostomy

3 (%15)

PCI, mean ± SD (range)

13.9 ± 3 (10–20)

  1. SD standard deviation, PCI peritoneal carcinomatozis index, Min minimum, Max maximum, A.P.R abdomino perineal resection, TAH + BSO total abdominal hysterectomy + bilateral salpingo-oophorectomy